Shin Nippon Biomedical Laboratories, Ltd.
1 clinical trials · Sponsor
◉ Watch Shin Nippon Biomedical Laboratories, Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting (NCT00787566) | Shin Nippon Biomedical Laboratories, Ltd. | 2008-10-01 |
Track Shin Nippon Biomedical Laboratories, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.